Organization
Emalex Biosciences
11 clinical trials
Clinical trial
A Multicenter, Open-Label, Extension Study Intended to Evaluate the Long-term Safety of Ecopipam Tablets in Children and Adolescent Subjects With Tourette's SyndromeStatus: Completed, Estimated PCD: 2022-11-11
Clinical trial
Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 YearsStatus: Completed, Estimated PCD: 2019-12-01
Clinical trial
A Phase 1, Single Center, Randomized (2-Sequence), Single Blind, 3-Period Study Comparing the Safety, Tolerability, and Pharmacokinetics of Ecopipam Controlled Release Capsules With Ecopipam HCl Immediate Release Tablets in Male Adult VolunteersStatus: Completed, Estimated PCD: 2012-02-01
Clinical trial
A Phase 1, Sequential Drug Interaction Study to Evaluate the Effect of CYP3A4 and P-glycoprotein Inhibition by Itraconazole or Induction by Rifampicin on the Pharmacokinetics of Ecopipam and Its Metabolites in Healthy SubjectsStatus: Recruiting, Estimated PCD: 2024-05-01
Clinical trial
A Multicenter, Open-Label, Study to Evaluate the Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's DisorderStatus: Recruiting, Estimated PCD: 2024-11-01
Clinical trial
An Outpatient Phase 3 Efficacy Study of Ecopipam (PSYRX 101) in the Symptomatic Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan DiseaseStatus: Terminated, Estimated PCD: 2013-12-01
Clinical trial
A Multicenter, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Maintenance of Efficacy of Ecopipam in Children, Adolescents and Adults With Tourette's DisorderStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Multicenter, Placebo-Controlled, Double-Blind, Randomized, Parallel-Group, Phase 2b Study to Evaluate the Efficacy and Safety of Ecopipam in Children and Adolescents With Tourette's SyndromeStatus: Completed, Estimated PCD: 2021-09-23
Clinical trial
A Phase 1, Open-Label, Fixed Sequence, Drug-Drug Interaction Study to Evaluate the Effects of Repeat Titrated Doses of Ecopipam on the Pharmacokinetics of Multiple Substrates for Drug Metabolism and Transport in Healthy SubjectsStatus: Completed, Estimated PCD: 2022-08-01
Clinical trial
A Randomized, Double-Blind, Placebo- and Positive Controlled, Crossover, Thorough QT/QTc Study to Evaluate the Effects of a Therapeutic and Supratherapeutic Dose of Ecopipam (EBS-101) on Cardiac Repolarization in Healthy SubjectsStatus: Completed, Estimated PCD: 2023-05-07
Clinical trial
Ecopipam Treatment of Pathological GamblingStatus: Completed, Estimated PCD: 2012-05-01